Sunshine Biopharma Inc. (SBFM)
2.27
-0.02 (-0.87%)
At close: Mar 03, 2025, 3:59 PM
2.31
1.76%
After-hours: Mar 03, 2025, 04:00 PM EST
Sunshine Biopharma Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| PE Ratio | -1.47 | -0.36 | -0.6 | -1.51 | -1.09 | -226.09 | -19.97K | -971.89 | -480.7 | -2.09K | -7.28K | -47.88K | -38.54K | -79.82K | n/a | -607.85K | -1.44M |
| PEG Ratio | 0.02 | 0.01 | -0.00 | -0.06 | -0.00 | -0.46 | 233.46 | 24.84 | 9.89 | 57.45 | -36.38 | -2.31K | 1.1K | n/a | n/a | -4.44K | n/a |
| PS Ratio | 0.27 | 2.24 | 33.42 | 19.04 | 75.21 | 1.09K | n/a | n/a | 465.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 0.31 | 0.45 | 36.06 | -1.42 | -2.16 | -8.74K | -36.22K | -16.21K | -1.33K | -10.43K | -2.35M | 481.32K | 208.12K | 218.61K | 12M | -1.07M | 1.41M |
| P/FCF Ratio | -0.69 | -1.75 | -4.17 | -2.06 | -3.2 | -916.92 | -37.95K | -10.7K | -532.82 | -7.51K | -32.13K | -86.24K | -72.11K | -123.15K | -114.77M | -686.71K | -6.06M |
| P/OCF Ratio | -0.75 | -1.85 | -4.17 | -2.07 | -3.2 | -950.63 | -38.21K | -10.82K | -915.77 | -7.51K | -32.13K | -86.24K | -72.11K | -123.15K | -114.77M | -686.71K | -6.06M |
| OCF/S Ratio | -0.36 | -1.21 | -8.01 | -9.2 | -23.47 | -1.15 | n/a | n/a | -507.99 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.03 | 0.20 | 8.98 | -2 | -0.97 | -17.09 | -1.4 | -1.13 | -1.91 | -1.24 | -1.62 | 0.89 | n/a | n/a | 0.32 | -0.96 | n/a |
| Quick Ratio | 3.45 | 3.47 | 22.91 | 0.95 | 0.06 | 0.23 | 0.17 | 0.21 | 0.04 | 0.27 | 0.80 | 2.09 | 31.00 | 18.21 | 7.83 | 0.22 | 9.93 |
| Current Ratio | 4.48 | 3.94 | 24.07 | 0.98 | 0.08 | 0.23 | 0.16 | 0.21 | 0.04 | 0.27 | 0.80 | 2.09 | 31.00 | 18.21 | 7.83 | 0.22 | 9.93 |
| Asset Turnover | 0.88 | 0.15 | 0.10 | 0.07 | 0.22 | 0.39 | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -34.85 | -220.09 | -7.42 | -3.43 | -5.54 | -7.32 | -8.18 | -28.59 | -2.54 | -9.8 | -299.93 | -555.57 | n/a | n/a | n/a | -5.19 | 1.00 |
| Return on Equity (ROE) | -0.21 | -1.24 | -60.31 | 0.94 | 1.99 | 38.67 | 1.81 | 16.67 | 2.77 | 4.99 | 323.15 | -10.05 | -5.4 | -2.74 | n/a | 1.76 | -0.98 |
| Return on Assets (ROA) | -0.16 | -0.91 | -5.79 | -0.86 | -14.89 | -1.88 | -4.04 | -54.29 | -2.46 | -13.49 | -79.75 | -5.25 | -5.23 | -2.59 | n/a | -6.19 | -0.88 |
| Return on Capital (ROIC) | -0.22 | -0.39 | -1.16 | 98.93 | 0.87 | -4.98 | 1.74 | 4.74 | 1.31 | 4.53 | 251.11 | -10.03 | -5.4 | -2.74 | -0.16 | 1.47 | -0.98 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 34.61% | 39.04% | 48.42% | 63.80% | 47.68% | 12.55% | n/a | n/a | -22.42K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -18.7% | -615.44% | -5.59K% | -1.26K% | -6.92K% | -482.15% | n/a | n/a | -96.77K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -17.06% | -610.07% | -5.44K% | -3.9K% | -5.1K% | -482.15% | n/a | n/a | -96.77K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -19.86% | -199.6% | -1.07K% | -807.83% | -3.04K% | -260.85% | n/a | n/a | -45.68K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -39.69% | -127.79% | -800.75% | -922.13% | -2.35K% | -118.89% | n/a | n/a | -87.31K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -15.87% | -608.58% | -5.29K% | -3.64K% | -4.49K% | -434.96% | n/a | n/a | -78.54K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |